Riskpilot← Back to searchSign inGet full accessCore Med Tech Development ApS
APSActiveCVR 37703788Gydevang 35, st.Activities of holding companies · NACE 6421Est. 2016— employees
Revenue 2025
DKK -221K
+160% vs 2024
EBITDA margin
100.0%
-160% vs 2024
Equity ratio
91.3%
Financial strength
Net profit 2025
DKK -99K
-106% vs 2024
| Revenue | DKK -221K | +160% |
| EBITDA | DKK -221K | -160% |
| Net profit | DKK -99K | -106% |
| Total assets | DKK 16,4M | +0% |
| Equity | DKK 15M | -7% |
| Employees | — | — |
Legal name
Core Med Tech Development ApS
CVR number
37703788
Legal form
Anpartsselskab
NACE code
6421 · Activities of holding companies
Founded
23. maj 2016
Share capital
DKK 50.000
Employees
—
VAT registered
Yes
Audit selected
Yes
Last report
2025-04-30
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør
Company purpose
Selskabets formål er at udøve virksomhed med industri, handel og service samt aktiviteter i tilknytning hertil og at fungere som holdingselskab.
Address
Gydevang 35, st.
Phone
+4540405345
Email
sv@coremedtech.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | -5 | -9 | -8 | -52 | -1.770 | -13 | -32 | -85 | -221 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -5 | -9 | -8 | -52 | -1.770 | -13 | -32 | -85 | -221 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -5 | -9 | -8 | -52 | -1.770 | -13 | -32 | -85 | -221 |
| Net financials | 2.540 | 3.379 | 7.131 | 1.900 | 37.723 | -4.269 | 1.310 | 1.779 | 219 |
| Profit before tax | 2.535 | 3.370 | 7.123 | 1.848 | 35.953 | -4.283 | 1.279 | 1.694 | -2 |
| Tax | -102 | -139 | -83 | -34 | -0 | 58 | 56 | 49 | 97 |
| Net profit | 2.637 | 3.509 | 7.206 | 1.881 | 35.953 | -4.341 | 1.223 | 1.646 | -99 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | 16.913 | 19.595 | 21.397 | 17.135 | 27.087 | 17.057 | 16.755 | 16.497 | 16.431 |
| Equity | 4.948 | 8.250 | 15.244 | 16.126 | 27.079 | 16.738 | 15.961 | 16.106 | 15.007 |
| Long-term debt | 9.185 | 6.585 | 2.203 | 544 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 2.780 | 4.760 | 3.950 | 465 | 8 | 319 | 795 | 390 | 1.424 |
| Total debt | 11.965 | 11.345 | 6.153 | 1.009 | 8 | 319 | 795 | 390 | 1.424 |
EBITDA margin
-22093300.0%
This company
15.8%
Market median
-139831113% vs market
20172025
Equity ratio
91.3%
This company
38.2%
Market median
+139% vs market
20172025
Return on equity
-0.7%
This company
18.4%
Market median
-104% vs market
20172025
Net profit margin
-9903700.0%
This company
8.1%
Market median
-122268001% vs market
20172025
Asset turnover
-0.01×
This company
1.12×
Market median
-101% vs market
20172025
Debt / equity
0.09×
This company
0.62×
Market median
+85% vs market
20172025
- Annual report 2025Filed via CVR / Virk · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via CVR / Virk · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via CVR / Virk · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via CVR / Virk · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via CVR / Virk · Period 2020-05-01 – 2021-04-30
- Annual report 2020Filed via CVR / Virk · Period 2019-05-01 – 2020-04-30
- Annual report 2019Filed via CVR / Virk · Period 2018-05-01 – 2019-04-30
- Annual report 2018Filed via CVR / Virk · Period 2017-05-01 – 2018-04-30
- Annual report 2017Filed via CVR / Virk · Period 2016-05-23 – 2017-04-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
SV Management | Management | 2016 | — | — |
CS Management | Management | 2016 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
SASSER G HOLDING ApS | Company | 50.0% | 50.0% | 2016 |
Baltho Holding ApS | Company | 50.0% | 50.0% | 2016 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
SASSER G HOLDING ApS
Core Med Tech Development ApS Board members of Core Med Tech Development ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Steffen Vogel | Management | 0 companies |
| Christian Schärfe Baltzer-Thomsen | Management | 0 companies |